Freescale-NXP Merger Leaves Fewer Viable Alternatives in Chip Market
Dale Ford, Vice President, Semiconductors & Components, IHS Technology
Electronics360 (March 2, 2015)
The announced merger of Freescale Semiconductor Inc. and NXP Semiconductor for $11.8 billion has important implications from a buyer-side perspective.
When Renesas and NEC merged, many companies were left looking for another second source supplier, and they turned to Freescale and NXP. Now, with the merger of these two companies, there are pluses and minuses. First, the combined company should have greater resources to devote to support the significant pick-up of customers they took from Renesas/NEC when they went looking for another second source. But, second, the industry consolidation just became that much greater meaning as there are fewer viable alternatives of major suppliers for vendors to choose from.
|
|
E-mail This Article |
|
Printer-Friendly Page |
Related News
- What Freescale-NXP Merger Can Teach Us
- ASOCS and CMCC team up to deliver mass market high capacity, commercially viable C-RAN solutions
- SOC market opportunities favor fewer players, says research firm
- VSORA Raises $46 Million to Bring World's Most Powerful AI Inference Chip to Market
- Alphawave Semi Reveals Suite of Optoelectronics Silicon Products addressing Hyperscaler Datacenter and AI Interconnect Market
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






